Keith Holmes - Concepedia

Author

Keith Holmes

St George's Hospital

Also Known As

Holmes, Keith, J. Hendrickson, K Holmes, K. Holmes, KEITH HOLMES, Keith Holmes, Keith Holmes *

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

St George's Hospital Institut Gustave Roussy Hospital Universitari i Politècnic La Fe Istituto Giannina Gaslini St Anna Children's Hospital

About

Keith Holmes is an author at St George's Hospital specializing in medicine, education, and education policy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.1K
2	Education	5	5	212
3	Engineering	2	2	35
4	Health Sciences	2	2	23
5	Public Health	2	2	43

Keith Holmes

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report Tom Monclair, Garrett M. Brodeur, Peter F. Ambros, Journal of Clinical Oncology	2008	1.1K
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial Ruth Ladenstein, Ulrike Pötschger, Dominique Valteau‐Couanet, The Lancet Oncology Interleukin 2Autoimmune DiseaseAnti-gd2 Antibody Ch14.18/choImmunologyPathology	2018	379
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial Ruth Ladenstein, Ulrike Pötschger, Andrew D.J. Pearson, The Lancet Oncology OncologyMedicineVersus CarboplatinImmune Checkpoint InhibitorHigh-dose Chemotherapy	2017	334
Surgical Risk Factors in Primary Surgery for Localized Neuroblastoma: The LNESG1 Study of the European International Society of Pediatric Oncology Neuroblastoma Group Giovanni Cecchetto, Véronique Mosseri, Bruno De Bernardi, Journal of Clinical Oncology	2005	208
Referral patterns for specialist child and adolescent mental health services in the Republic of Ireland during the COVID-19 pandemic compared with 2019 and 2018 Fiona McNicholas, Ian Kelleher, Elma Hedderman, BJPsych Open	2021	207
Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1) Ruth Ladenstein, Ulrike Pötschger, Dominique Valteau‐Couanet, Cancers	2020	139
Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN Study Keith Holmes, Ulrike Pötschger, Andrew D.J. Pearson, Journal of Clinical Oncology	2020	117
Excellent Outcome With Reduced Treatment in Infants With Nonmetastatic and Unresectable Neuroblastoma Without <i>MYCN</i> Amplification: Results of the Prospective INES 99.1 Hervé Rubie, Bruno De Bernardi, Mary Gerrard, Journal of Clinical Oncology	2010	107
Image‐defined risk factors in unresectable neuroblastoma: SIOPEN study on incidence, chemotherapy‐induced variation, and impact on surgical outcomes Stefano Avanzini, Luca Pio, Giovanni Erminio, Pediatric Blood & Cancer	2017	104
Challenges for Educational Research: International development, partnerships and capacity building in small states Michael Crossley, Keith Holmes Oxford Review of Education Public PolicyInternational ResearchEducational PolicyInclusive EducationSocial Foundations Of Education	2001	92

Page 1